Ashland Inc. <ASH.N>: Argus Research Raises Target Price to $80 From $64
ASH•Related News
Anixa Biosciences presents at Cantor Fitzgerald Global Healthcare Conference on breast cancer vaccine progress
ANIX•
Athene shifts CLO exposure toward AMAPS, citing tighter spreads in CLO market
APO•
CVRx shareholder Chernett urges board to start immediate sale process to strategic buyer
CVRX•
Tempus AI wins FDA clearance for ECG software flagging pulmonary hypertension signs
TEM•
Buzz-U.S. Stocks on the Move-Jersey Mike's Sub, Moderna, PDD Holding
SPY•